These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3329022)

  • 1. [Dopaminergic stimulation in cardiology: its current status and future strategies].
    Cherchi A; Mercuro G
    Cardiologia; 1987 Dec; 32(12):1631-9. PubMed ID: 3329022
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification and characterization of dopamine receptors in the cardiovascular system.
    Goldberg LI; Kohli JD
    Cardiologia; 1987 Dec; 32(12):1603-7. PubMed ID: 3447717
    [No Abstract]   [Full Text] [Related]  

  • 3. [DA2-type dopamine receptors: the physiological and clinical implications in cardiology].
    Mercuro G; Rivano CA; Lai L; Longu G; Cherchi A
    Cardiologia; 1987 Dec; 32(12):1623-30. PubMed ID: 2965981
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dopaminergic receptors in the cardiovascular system: their biochemical characterization and pharmacological importance].
    Missale C; Liberini P; Lombardi C; De Cotiis R; Memo M; Spano PF
    Cardiologia; 1987 Dec; 32(12):1613-6. PubMed ID: 3329021
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopamine: pharmacologic and therapeutic aspects.
    Velasco M; Luchsinger A
    Am J Ther; 1998 Jan; 5(1):37-43. PubMed ID: 10099036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term administration of dopamine: is there a development of tolerance?
    Braun GG; Bahlmann F; Brandl M; Knoll R
    Prog Clin Biol Res; 1989; 308():1097-9. PubMed ID: 2550954
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological bases for the use of dopamine and related drugs in the treatment of congestive heart failure.
    Goldberg LI
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S21-8. PubMed ID: 2483439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Peripheral dopamine DA1-type receptors: their localization, functional role and possible clinical implications].
    Mannelli M; Pupilli C; Baldi E; DeFeo ML
    Cardiologia; 1987 Dec; 32(12):1617-21. PubMed ID: 2965980
    [No Abstract]   [Full Text] [Related]  

  • 9. AR-L115BS in the treatment of heart failure.
    Thormann J; Kramer W; Schlepper M; Gottwick M
    Eur Heart J; 1982 Dec; 3 Suppl D():87-95. PubMed ID: 7160400
    [No Abstract]   [Full Text] [Related]  

  • 10. [Problems of long-term therapy and therapeutic damage considering the clinical aspects. Cardiology].
    Lüderitz B
    Verh Dtsch Ges Inn Med; 1991; 97():34-43. PubMed ID: 1808909
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cardiovascular pharmacology (IX). Angiotensin-converting enzyme inhibitors in hypertension and heart failure].
    de Teresa E; Espinosa JS; Gómez Doblas JJ
    Rev Esp Cardiol; 1995 Feb; 48(2):128-41. PubMed ID: 7886264
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cardiovascular effects of dopamine: physiopathogenic implications of the regulation of arterial tension].
    Cuche JL; Kuchel O; Barbeau A; Boucher R GENEST J
    Union Med Can; 1972 Oct; 101(10):2090-3. PubMed ID: 4642695
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dopamine and the cardiovascular system].
    Jarecki M; Cybulska I
    Kardiol Pol; 1972; 15(2):241-7. PubMed ID: 4403277
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical use of dopamine].
    Goldberg LI; Hsieh YY
    Internist (Berl); 1978 Jul; 19(7):427-30. PubMed ID: 357329
    [No Abstract]   [Full Text] [Related]  

  • 15. [Currently used positive inotropic substances].
    Hauf GF; Grom E
    Ther Umsch; 1984 Feb; 41(2):111-6. PubMed ID: 6369614
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dopamine receptors in the cardiocirculatory system: an autoradiographic study].
    Amenta F; De Rossi M; Ricci A; Amenta D
    Cardiologia; 1987 Dec; 32(12):1609-12. PubMed ID: 3329020
    [No Abstract]   [Full Text] [Related]  

  • 17. [Heart failure in coronary heart disease].
    Hauf GF; Roskamm H
    Internist (Berl); 1993 Oct; 34(10):953-60. PubMed ID: 8225845
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of drugs interacting with the dopaminergic receptors on glucose levels and insulin release in healthy and type 2 diabetic subjects.
    Contreras F; Foullioux C; Pacheco B; Maroun C; Bolívar H; Lares M; Leal E; Cano R; Bermúdez V; Velasco M
    Am J Ther; 2008; 15(4):397-402. PubMed ID: 18645345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of ouabain on the cardiovascular system of rats with chronic heart failure].
    Gorodetskaia EA; Allabergenova EA; Medvedev OS
    Eksp Klin Farmakol; 1993; 56(1):31-3. PubMed ID: 8324469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical efficacy of oral dopaminergic agents: new findings].
    Dei Cas L; Metra M; Nodari S; Raccagni D
    Cardiologia; 1995 Dec; 40(12 Suppl 1):131-8. PubMed ID: 8998705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.